PE20090216A1 - Compuestos triazolil aminopirimidina - Google Patents
Compuestos triazolil aminopirimidinaInfo
- Publication number
- PE20090216A1 PE20090216A1 PE2008000798A PE2008000798A PE20090216A1 PE 20090216 A1 PE20090216 A1 PE 20090216A1 PE 2008000798 A PE2008000798 A PE 2008000798A PE 2008000798 A PE2008000798 A PE 2008000798A PE 20090216 A1 PE20090216 A1 PE 20090216A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- methyl
- compounds
- thiofen
- pirrol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DE FORMULA I, EN EL QUE R1 ES HIDROXI, AMINO(ALQUILO C1-C4), (2-HIDROXI-2-METIL)-1-PROPILOXI, ENTRE OTROS; R2 ES H O AMINO, SIEMPRE QUE SI R2 ES AMINO, R1 Y R2 FORMAN UN ANILLO PIRROL FUSIONADO AL FENILO O SI R1 ES AMINO, R1 Y R2 PUEDEN FORMAR YA SEA UN ANILLO PIRROL O PIRIDINA FUSIONADO AL FENILO; R3 ES H, Cl O F; R4 ES H, METILO, Cl O F; R5 Y R6 SON H, HIDROXIMETILO O METILO. SON SELECCIONADOS: 2-(2-(2-(2-(2-(1H-1,2,3-TRIAZOL-1-IL)ETILAMINO)-5-FLUOROPIRIMIDIN-4-IL)BENZO[b]TIOFEN-7-IL)FENOXI)ETANOL, N-(2-(1H-1,2,3-TRIAZOL-1-IL)ETIL)-5-FLUORO-4-(7-(5-FLUORO-1H-INDOL-7-IL)BENZO[b]TIOFEN-2-IL)PIRIMIDIN-2-AMINA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCESO DE PREPARACION Y COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE P1K1 UTILES EN EL TRATAMIENTO DEL CANCER
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93834707P | 2007-05-16 | 2007-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090216A1 true PE20090216A1 (es) | 2009-02-28 |
Family
ID=39951591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008000798A PE20090216A1 (es) | 2007-05-16 | 2008-05-07 | Compuestos triazolil aminopirimidina |
Country Status (15)
Country | Link |
---|---|
US (1) | US8063035B2 (es) |
EP (1) | EP2155734A2 (es) |
JP (1) | JP5248600B2 (es) |
KR (1) | KR101131261B1 (es) |
CN (1) | CN101679395B (es) |
AR (1) | AR066473A1 (es) |
AU (1) | AU2008254319B2 (es) |
BR (1) | BRPI0811433A2 (es) |
CA (1) | CA2691997A1 (es) |
CL (1) | CL2008001323A1 (es) |
EA (1) | EA016781B1 (es) |
MX (1) | MX2009012228A (es) |
PE (1) | PE20090216A1 (es) |
TW (1) | TW200908981A (es) |
WO (1) | WO2008144223A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7964729B2 (en) | 2006-08-28 | 2011-06-21 | Massachusetts Institute Of Technology | Sox-based kinase sensor |
ES2351371T3 (es) | 2006-12-21 | 2011-02-03 | ELI LILLY & COMPANY | Compuestos de imidazolidinonil aminopirimidina para el tratamiento del cáncer . |
BRPI0721045A2 (pt) | 2006-12-21 | 2014-07-29 | Lilly Co Eli | Compostos de aminopirimidina de imidazolidinonila para o tratamento do câncer |
US8440835B2 (en) | 2007-02-26 | 2013-05-14 | Massachusetts Institute Of Technology | Environmentally sensitive fluorophores |
PE20090216A1 (es) | 2007-05-16 | 2009-02-28 | Lilly Co Eli | Compuestos triazolil aminopirimidina |
EA015574B1 (ru) * | 2007-05-16 | 2011-10-31 | Эли Лилли Энд Компани | Триазолиламинопиримидиновые соединения |
KR101123178B1 (ko) * | 2009-04-09 | 2012-06-13 | (주)에스메디 | 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물 |
CN102597236A (zh) * | 2009-08-25 | 2012-07-18 | 肿瘤疗法科学股份有限公司 | 癌症治疗和诊断的靶基因ercc6l |
US8409820B2 (en) | 2009-08-31 | 2013-04-02 | Massachusetts Institute Of Technology | Kinase sensors |
UA119247C2 (uk) | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
US9611201B2 (en) * | 2015-03-05 | 2017-04-04 | Karos Pharmaceuticals, Inc. | Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone |
EP3475280B1 (en) * | 2016-06-23 | 2020-04-08 | H. Hoffnabb-La Roche Ag | Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives |
US11084829B2 (en) | 2018-09-24 | 2021-08-10 | Rapt Therapeutics, Inc. | Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof |
MX2022002601A (es) * | 2019-09-05 | 2022-06-02 | Univ Melbourne | Inhibidores de la nitrificacion. |
CN112341428A (zh) * | 2020-11-04 | 2021-02-09 | 菏泽鸿特药业有限公司 | 一种噻吩-2-乙胺的生产方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929726A (en) * | 1988-02-09 | 1990-05-29 | Georgia State University Foundation, Inc. | Novel diazines and their method of preparation |
WO2004063192A1 (en) | 2003-01-10 | 2004-07-29 | Pharmacopeia Drug Discovery, Inc. | Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators |
GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
WO2005012283A1 (en) * | 2003-07-31 | 2005-02-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzothiophene compounds and uses thereof |
US7786132B2 (en) | 2004-12-17 | 2010-08-31 | Amgen Inc. | Aminopyrimidine compounds and methods of use |
TW200800201A (en) | 2005-11-18 | 2008-01-01 | Lilly Co Eli | Pyrimidinyl benzothiophene compounds |
EP2001480A4 (en) | 2006-03-31 | 2011-06-15 | Abbott Lab | Indazole CONNECTIONS |
ES2351371T3 (es) * | 2006-12-21 | 2011-02-03 | ELI LILLY & COMPANY | Compuestos de imidazolidinonil aminopirimidina para el tratamiento del cáncer . |
BRPI0721045A2 (pt) | 2006-12-21 | 2014-07-29 | Lilly Co Eli | Compostos de aminopirimidina de imidazolidinonila para o tratamento do câncer |
EA015574B1 (ru) | 2007-05-16 | 2011-10-31 | Эли Лилли Энд Компани | Триазолиламинопиримидиновые соединения |
PE20090216A1 (es) | 2007-05-16 | 2009-02-28 | Lilly Co Eli | Compuestos triazolil aminopirimidina |
-
2008
- 2008-05-07 PE PE2008000798A patent/PE20090216A1/es not_active Application Discontinuation
- 2008-05-07 CL CL2008001323A patent/CL2008001323A1/es unknown
- 2008-05-07 WO PCT/US2008/062808 patent/WO2008144223A2/en active Application Filing
- 2008-05-07 CN CN2008800157689A patent/CN101679395B/zh not_active Expired - Fee Related
- 2008-05-07 EP EP08747731A patent/EP2155734A2/en not_active Withdrawn
- 2008-05-07 EA EA200971068A patent/EA016781B1/ru not_active IP Right Cessation
- 2008-05-07 AU AU2008254319A patent/AU2008254319B2/en not_active Ceased
- 2008-05-07 JP JP2010508500A patent/JP5248600B2/ja not_active Expired - Fee Related
- 2008-05-07 KR KR1020097023340A patent/KR101131261B1/ko not_active IP Right Cessation
- 2008-05-07 AR ARP080101932A patent/AR066473A1/es unknown
- 2008-05-07 BR BRPI0811433A patent/BRPI0811433A2/pt not_active IP Right Cessation
- 2008-05-07 US US12/598,926 patent/US8063035B2/en not_active Expired - Fee Related
- 2008-05-07 MX MX2009012228A patent/MX2009012228A/es active IP Right Grant
- 2008-05-07 CA CA002691997A patent/CA2691997A1/en not_active Abandoned
- 2008-05-07 TW TW097116886A patent/TW200908981A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CL2008001323A1 (es) | 2009-05-29 |
WO2008144223A2 (en) | 2008-11-27 |
JP5248600B2 (ja) | 2013-07-31 |
US20100087431A1 (en) | 2010-04-08 |
KR101131261B1 (ko) | 2012-04-24 |
EA200971068A1 (ru) | 2010-04-30 |
AU2008254319B2 (en) | 2012-04-19 |
EP2155734A2 (en) | 2010-02-24 |
JP2010527365A (ja) | 2010-08-12 |
EA016781B1 (ru) | 2012-07-30 |
CA2691997A1 (en) | 2008-11-27 |
US8063035B2 (en) | 2011-11-22 |
TW200908981A (en) | 2009-03-01 |
KR20090130242A (ko) | 2009-12-21 |
AR066473A1 (es) | 2009-08-19 |
MX2009012228A (es) | 2009-12-01 |
CN101679395A (zh) | 2010-03-24 |
AU2008254319A1 (en) | 2008-11-27 |
BRPI0811433A2 (pt) | 2016-03-22 |
CN101679395B (zh) | 2012-06-13 |
WO2008144223A3 (en) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090216A1 (es) | Compuestos triazolil aminopirimidina | |
PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
PE20061305A1 (es) | Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas | |
PE20081845A1 (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
AR054214A1 (es) | Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c. | |
PE20081447A1 (es) | Compuestos y composiciones como inhibidores de la proteina cinasa | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
PE20080925A1 (es) | DERIVADOS DE PIRROLO[2,3-b]PIRIDINA COMO INHIBIDORES DE QUINASA, EN PARTICULAR INHIBIDORES IKK2 (O IKK BETA) | |
RS20090249A (en) | Spiroketone acetyl-coa carboxylase inhibotors | |
PE20080951A1 (es) | DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
MX2010006799A (es) | Benzofuropirimidinonas como inhibidores de la proteina cinasa. | |
AR065499A1 (es) | Inhibidores de serino proteasas.composiciones farmaceuticas | |
TW200612936A (en) | Indole derivatives | |
ATE438402T1 (de) | 4-anilino-chinazolin-derivate als proliferationshemmende mittel | |
BRPI0614493B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, processo para a preparação de um composto e o referido composto | |
UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
PE20100737A1 (es) | Nuevos compuestos | |
MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
TW200740827A (en) | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | |
ECSP109900A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |